(Reuters) - Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less ...

In a first-of-its-kind marketing move, Lipitor-manufacturer Pfizer wants to do all it can to make sure heart patients continue to buy their prescription brand. They're offering discount incentives to ...

Drug prices almost always fall after a manufacturer’s patent expires and generics hit the market. But with its blockbuster cholesterol-fighting drug Lipitor going off-patent this week, drug maker ...

Researchers are to examine whether or not cheap cholesterol-busting statins could help people with motor neurone disease (MND) live longer. People with the progressive neurodegenerative disease ...

During the first full week that generic Lipitor was available, the brand-name version accounted for less than half of the prescriptions for the... It's here. The cholesterol-fighter Liptor, the ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the ...

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

Over 140,000 bottles of Atorvastatin Calcium Tablets, a cholesterol-lowering medication, are being recalled due to "failed dissolution specifications," according to the Food and Drug Administration ...